Yes Russ I saw that paper on cormatrix failures. Shocking stuff and avoidable when something like cardiocel is now available. I think that's what they are tapping into right now and it has 6 years of data, and initial usage in mitral valves, which currently has only short term data but from all reports has shown impressive results. European finest surgeons are calling it the best xenograft material available. It has all the signs they just need the time of take up which is slower than we would all like but is inevitable.
Where's The Report?, page-43
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.91 |
Change
-0.090(0.50%) |
Mkt cap ! $344.2M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.75 | $74.32K | 4.151K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 681 | $17.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.25 | 100 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |